Hepatocyte growth factor enhances adhesion of breast cancer cells to endothelial cells in vitro through up-regulation of CD44

Experimental Cell Research

Volumn 288, Issue 1, 2003, Pages 189-197

  Mine, Shinichiro ^a   Fujisaki, Takeshi ^a   Kawahara, Chie ^a   Tabata, Takahiro ^a   Iida, Takeshi ^a   Yasuda, Manabu ^a   Yoneda, Toshiyuki ^b   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Adhesion; Breast cancer; CD44; HGF; Metastasis

Indexed keywords

HERMES ANTIGEN; PROTEIN TYROSINE KINASE; SCATTER FACTOR;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; METASTASIS; PRIORITY JOURNAL; SHEAR STRESS; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 0038148918     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00184-8     Document Type: Article

References (52)

1. Al-Mehdi A.B., Tozawa K., Fisher A.B., Shientag L., Lee A., Muschel R.J. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nature Med. 6:2000;100-102.
2. Albelda S.M. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab. Invest. 68:1993;4-17.
3. Behrens J. The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res. Treat. 24:1993;175-184.
4. Duffy M.J. The biochemistry of metastasis. Adv. Clin. Chem. 32:1996;135-166.
5. Butcher E.C. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell. 67:1991;1033-1036.
6. Shimizu Y., Newman W., Tanaka Y., Shaw S. Lymphocyte interactions with endothelial cells. Immunol. Today. 13:1992;106-112.
7. Tanaka Y., Albelda S.M., Horgan K.J., van Seventer G., Shimizu Y., Newman W., Hallam J., Newman P.J., Buck C.A., Shaw S. CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrin-mediated adhesion. J. Exp. Med. 176:1992;245-253.
8. Tanaka Y., Kimata K., Wake A., Mine S., Morimoto I., Yamakawa N., Habuchi H., Ashikari S., Yamamoto H., Sakurai K., Yoshida K., Suzuki S., Eto S. Heparan sulfate proteoglycan on leukemic cells is primarily involved in integrin triggering and its mediated adhesion to endothelial cells. J. Exp. Med. 184:1996;1987-1997.
9. Tanaka Y., Wake A., Horgan K.J., Murakami S., Aso M., Saito K., Oda S., Morimoto I., Uno H., Kikuchi H., Izumi Y., Eto S. Distinct phenotype of leukemic T cells with various tissue tropisms. J. Immunol. 158:1997;3822-3829.
10. Tanaka Y., Mine S., Figdor C.G., Wake A., Hirano H., Tsukada J., Aso M., Fujii K., Saito K., van K.Y., Eto S. Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells. Blood. 91:1998;3909-3919.
11. Gunthert U. CD44: a multitude of isoforms with diverse functions. Curr. Top. Microbiol. Immunol. 184:1993;47-63.
12. Lesley J., Hyman R., Kincade P.W. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:1993;271-335.
13. Naot D., Sionov R.V., Ish S.D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71:1997;241-319.
14. Shimizu Y., van Seventer G.A., Siraganian R., Wahl L., Shaw S. Dual role of the CD44 molecule in T cell adhesion and activation. J. Immunol. 143:1989;2457-2463.
15. Jackson D.G., Bell J.I., Dickinson R., Timans J., Shields J., Whittle N. Proteoglycan forms of the lymphocyte homing receptor CD44 are alternatively spliced variants containing the v3 exon. J. Cell Biol. 128:1995;673-685.
16. Fujisaki T., Tanaka Y., Fujii K., Mine S., Saito K., Yamada S., Yamashita U., Irimura T., Eto S. CD44 stimulation induces integrin-mediated adhesion of colon cancer cell lines to endothelial cells by up-regulation of integrins and c-Met and activation of integrins. Cancer Res. 59:1999;4427-4434.
17. Yoneda T. Cellular and molecular basis of preferential metastasis of breast cancer to bone. J. Orthop. Sci. 5:2000;75-81.
18. Hraga T., Williams P.J., Mundy G.R., Yoneda T. The bisphosphonate ibandronate promote apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res. 61:2001;4418-4424.
19. Hiscox S., Jiang W.G. Regulation of endothelial CD44 expression and endothelium-tumour cell interactions by hepatocyte growth factor/scatter factor. Biochem. Biophys. Res. Commun. 233:1997;1-5.
20. Tanaka Y., Mine S., Hanagiri T., Hiraga T., Morimoto I., Figdor C.G., van Kooyk Y., Ozawa H., Nakamura T., Yasumoto K., Eto S. Constitutive up-regulation of integrin-mediated adhesion of tumor-infiltrating lymphocytes to osteoblasts and bone marrow-derived stromal cells. Cancer Res. 58:1998;4138-4145.
21. Tanaka Y., Kimata K., Adams D.H., Eto S. Modulation of cytokine function by heparan sulfate proteoglycans: sophisticated models for the regulation of cellular responses to cytokines. Proc. Assoc. Am. Phys. 110:1998;118-125.
22. Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., Matzku S., Wenzel A., Ponta H., Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell. 65:1991;13-24.
23. Stamenkovic I., Amniot M., Pesando J.M., Seed B. A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell. 56:1989;1057-1062.
24. Dall P., Heider K.H., Sinn H.P., Skroch-Angel P., Adolf G., Kaufmann M., Herrlich P., Ponta H. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. Int. J. Cancer. 60:1995;471-477.
25. Abbot S.E., Kaul A., Stevens C.R., Blake D.R. Isolation and culture of synovial microvascular endothelial cells. Characterization and assessment of adhesion molecule expression. Arthritis Rheum. 35:1992;401-406.
26. Hewett PW, .Murray JC. Human microvessel endothelial cells: isolation, culture and characterization. In Vitro Cell Dev. Biol. Anim. 1993;823-830.
27. Tanaka Y., Fujii K., Hubscher S., Aso M., Takazawa A., Saito K., Ota T., Eto S. Heparan sulfate proteoglycan on endothelium efficiently induces integrin-mediated T cell adhesion by immobilizing chemokines in patients with rheumatoid synovitis. Arthritis Rheum. 41:1998;1365-1377.
28. Imai K., Kobayashi M. Differences between bone marrow and lung endothelial cells. Semin. Thromb. Hemostasis. 24:1998;275-277.
29. Mine S., Tanaka Y., Suematu M., Aso M., Fujisaki T., Yamada S., Eto S. Hepatocyte growth factor is a potent trigger of neutrophil adhesion through rapid activation of lymphocyte function-associated antigen-1. Lab. Invest. 78:1998;1395-1404.
30. Lawrence M.B., Springer T.A. Leukocytes roll on a selectin at physiologic flow rates: distinction from and prerequisite for adhesion through integrins. Cell. 65:1991;859-873.
31. Bottaro D.P., Rubin J.S., Faletto D.L., Chan A.M., Kmiecik T.E., Vande G.W., Aaronson S.A. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 251:1991;802-804.
32. Zarnegar R., Michalopoulos G.K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 129:1995;1177-1180.
33. Adams D.H., Harvath L., Bottaro D.P., Interrante R., Catalano G., Tanaka Y., Strain A., Hubscher S.G., Shaw S. Hepatocyte growth factor and macrophage inflammatory protein 1 beta: structurally distinct cytokines that induce rapid cytoskeletal changes and subset-preferential migration in T cells. Proc. Natl. Acad. Sci. USA. 91:1994;7144-7148.
34. Weimar I.S., de J.D., Muller E.J., Nakamura T., van Gorp J.M., de Gast G.C., Gerritsen W.R. Hepatocyte growth factor/scatter factor promotes adhesion of lymphoma cells to extracellular matrix molecules via alpha 4 beta 1 and alpha 5 beta 1 integrins. Blood. 89:1997;990-1000.
35. van dem Vier R., Taher T.E., Keehnen R.M., Smit L., Groenink M., Pals S.T. Paracrine regulation of germinal center B cell adhesion through the c-met-hepatocyte growth factor/scatter factor pathway. J. Exp. Med. 185:1997;2121-2131.
36. Toi M., Taniguchi T., Ueno T., Asano M., Funata N., Sekiguchi K., Iwanari H., Tominaga T. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin. Cancer Res. 4:1998;659-664.
37. Maemura M., Iino Y., Yokoe T., Horiguchi J., Takei H., Koibuchi Y., Horii Y., Takeyoshi I., Ohwada S., Morishita Y. Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer. Cancer Lett. 126:1998;215-220.
38. Taniguchi T., Toi M., Inada K., Imazawa T., Yamamoto Y., Tominaga T. Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin. Cancer Res. 1:1995;1031-1034.
39. Yamashita J., Ogawa M., Yamashita S., Nomura K., Kuramoto M., Saishoji T., Shin S. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 54:1994;1630-1633.
40. Hiscox S., Jiang W.G. Association of the HGF/SF receptor, c-met, with the cell-surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem. Biophys. Res. Commun. 261:1999;406-411.
41. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
42. Shimizu Y., Newman W., Gopal T.V., Horgan K.J., Graber N., Beall L.D., van Seventer S.G., Shaw S. Four molecular pathways of T cell adhesion to endothelial cells: roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J. Cell Biol. 113:1991;1203-1212.
43. Dustin M.L., Singer K.H., Tuck D.T., Springer T.A. Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1). J. Exp. Med. 167:1988;1323-1340.
44. Beviglia L., Matsumoto K., Lin C.S., Ziober B.L., Kramer R.H. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression. Int. J. Cancer. 74:1997;301-309.
45. Nagy J., Curry G.W., Hillan K.J., McKay I.C., Mallon E., Purushotham A.D., George W.D. Hepatocyte growth factor/scatter factor expression and c-met in primary breast cancer. Surg. Oncol. 5:1996;15-21.
46. DeGrendele H.C., Estess P., Picker L.J., Siegelman M.H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183:1996;1119-1130.
47. Estess P., Nandi A., Mohamadzadeh M., Siegelman M.H. Interleukin 15 induces endothelial hyaluronan expression in vitro and promotes activated T cell extravasation through a CD44-dependent pathway in vivo. J. Exp. Med. 190:1999;9-19.
48. Wielenga V.J., van der Voort M.R., Taher T.E.I., Smit L., Beuling E.A., van Krimpen C., Spaargaren M., Pals S.T. Expression of c-met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer. Am. J. Pathol. 157:2000;1563-1573.
49. van der Voort R., Taher T.E.I., Wielenga V.J.M., Spaargaren M., Prevo R., Smit L., David G., Hartmann G., Gherardi E., Pals S.T. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-met. J. Biol Chem. 274:1999;6499-6506.
50. Victor R., Chauzy C., Girard N., Gioanni J., d'Anjou J., Stora D.N.H., Delpech B. Human breast-cancer metastasis formation in a nude-mouse model: studies of hyaluronidase, hyaluronan and hyaluronan-binding sites in metastatic cells. Int. J. Cancer. 82:1999;77-83.
51. Thomas R.J., Guise T.A., Yin J.J., Elliott J., Horwood N.J., Martin T.J., Gillespie M.T. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology. 140:1999;4451-4458.
52. Carron J.A., Fraser W.D., Gallagher J.A. PTHrP and the PTH/PTHrP receptor are co-expressed in human breast and colon tumours. Br. J. Cancer. 76:1997;1095-1098.